Cargando…
SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease
Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and viscera...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208809/ http://dx.doi.org/10.1210/jendso/bvaa046.673 |
_version_ | 1783530933130887168 |
---|---|
author | Gutierrez, Karla Paola Kornhauser, Carlos Gómez, Armando Luevano-Contreras, Claudia Fafutis-Morris, Mary Gugliucci, Alejandro Garay-Sevilla, Ma Eugenia |
author_facet | Gutierrez, Karla Paola Kornhauser, Carlos Gómez, Armando Luevano-Contreras, Claudia Fafutis-Morris, Mary Gugliucci, Alejandro Garay-Sevilla, Ma Eugenia |
author_sort | Gutierrez, Karla Paola |
collection | PubMed |
description | Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and visceral fat tissue, among others (2). There are few and controversial data that assess the levels of nesfatin-1 and its relationship with the cardiovascular disease. The aim of this study was to evaluate the serum levels of nesfatin-1 in adolescents with different metabolic status and BMI and its association with cardiovascular risk factors (glucose, lipid profile). Material and methods: This cross-sectional study included adolescents between 15 and 19 years old, classified in 3 groups according to BMI and HOMA-IR: adolescents with normal weight without metabolic alterations (n = 30), metabolically healthy obese (MHO) n = 30 and metabolically unhealthy obese adolescents (MUO) n = 42. Anthropometric measurements were performed, a fasting blood sample was taken to quantify glucose, lipid profile and creatinine. Insulin and nesfatin-1 concentrations were measured by ELISA. Statistical tests employed were Kruskal Wallis, Spearman correlation. Results: the group of adolescents MUO had higher levels of total-C (p<0.0002); triglycerides (p<0.00001) compared to the control and MHO; higher levels of nesfatin-1 (p=0.0002) and lower levels of HDL-C (p<0.002) compared to the control group. A positive correlation was between nesfatin-1 and BMI (p<0.001), triglycerides (p<0.027), and HOMA-IR (p<0.025) and negative correlation with HDL-C (p<0.026) Conclusion: Our results show that metabolically unhealthy obese adolescents have higher concentrations of nesfatin-1, showing an association with traditional cardiovascular risk factors, which could lead to the development of cardiovascular disease. Nothing to disclose GK, KC, GOA, LCC, FMM, GA, GSME Sources of research support: Grant University of Guanajuato (DAIP 302/2018) References: (1) Oh-I et al., Nature. 2006; 443:709–712. (2) Stengel A et al., Regulatory Peptides. 2010; 163:18–23 |
format | Online Article Text |
id | pubmed-7208809 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-72088092020-05-13 SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease Gutierrez, Karla Paola Kornhauser, Carlos Gómez, Armando Luevano-Contreras, Claudia Fafutis-Morris, Mary Gugliucci, Alejandro Garay-Sevilla, Ma Eugenia J Endocr Soc Cardiovascular Endocrinology Nesfastin-1 is a recently discovered anorexigenic neuropeptide, which seems to follow the signaling pathway of melanocortin, and is involved in cardiovascular regulation (1). It is expressed in several tissues, including pancreatic islet cells, the central nervous system, In subcutaneous and visceral fat tissue, among others (2). There are few and controversial data that assess the levels of nesfatin-1 and its relationship with the cardiovascular disease. The aim of this study was to evaluate the serum levels of nesfatin-1 in adolescents with different metabolic status and BMI and its association with cardiovascular risk factors (glucose, lipid profile). Material and methods: This cross-sectional study included adolescents between 15 and 19 years old, classified in 3 groups according to BMI and HOMA-IR: adolescents with normal weight without metabolic alterations (n = 30), metabolically healthy obese (MHO) n = 30 and metabolically unhealthy obese adolescents (MUO) n = 42. Anthropometric measurements were performed, a fasting blood sample was taken to quantify glucose, lipid profile and creatinine. Insulin and nesfatin-1 concentrations were measured by ELISA. Statistical tests employed were Kruskal Wallis, Spearman correlation. Results: the group of adolescents MUO had higher levels of total-C (p<0.0002); triglycerides (p<0.00001) compared to the control and MHO; higher levels of nesfatin-1 (p=0.0002) and lower levels of HDL-C (p<0.002) compared to the control group. A positive correlation was between nesfatin-1 and BMI (p<0.001), triglycerides (p<0.027), and HOMA-IR (p<0.025) and negative correlation with HDL-C (p<0.026) Conclusion: Our results show that metabolically unhealthy obese adolescents have higher concentrations of nesfatin-1, showing an association with traditional cardiovascular risk factors, which could lead to the development of cardiovascular disease. Nothing to disclose GK, KC, GOA, LCC, FMM, GA, GSME Sources of research support: Grant University of Guanajuato (DAIP 302/2018) References: (1) Oh-I et al., Nature. 2006; 443:709–712. (2) Stengel A et al., Regulatory Peptides. 2010; 163:18–23 Oxford University Press 2020-05-08 /pmc/articles/PMC7208809/ http://dx.doi.org/10.1210/jendso/bvaa046.673 Text en © Endocrine Society 2020. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Cardiovascular Endocrinology Gutierrez, Karla Paola Kornhauser, Carlos Gómez, Armando Luevano-Contreras, Claudia Fafutis-Morris, Mary Gugliucci, Alejandro Garay-Sevilla, Ma Eugenia SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title | SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title_full | SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title_fullStr | SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title_full_unstemmed | SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title_short | SUN-575 Levels of Nesfatin-1 in Adolescents, and Its Association with Body Mass Index and Risk of Cardiovascular Disease |
title_sort | sun-575 levels of nesfatin-1 in adolescents, and its association with body mass index and risk of cardiovascular disease |
topic | Cardiovascular Endocrinology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208809/ http://dx.doi.org/10.1210/jendso/bvaa046.673 |
work_keys_str_mv | AT gutierrezkarlapaola sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT kornhausercarlos sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT gomezarmando sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT luevanocontrerasclaudia sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT fafutismorrismary sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT gugliuccialejandro sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease AT garaysevillamaeugenia sun575levelsofnesfatin1inadolescentsanditsassociationwithbodymassindexandriskofcardiovasculardisease |